Evidence-based SGLT2 inhibitor and GLP-1 receptor agonist use by race in the VA healthcare system
Importance: Adoption of novel therapeutics often lags for Black versus non-Hispanic White patients. Seminal clinical trials established the cardiovascular efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in patients with type 2 di...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2025-06-01
|
| Colección: | American Journal of Preventive Cardiology |
| Materias: | |
| Acceso en línea: | http://www.sciencedirect.com/science/article/pii/S2666667725000388 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|